<DOC>
	<DOC>NCT03012841</DOC>
	<brief_summary>To demonstrate safety and effectiveness of the Arctic Front Advance™ and Freezor MAX® Cardiac CryoAblation Catheters for the treatment of drug refractory recurrent symptomatic persistent atrial fibrillation.</brief_summary>
	<brief_title>STOP Persistent AF</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Documentation of symptomatic persistent AF: Defined as having a continuous episode lasting longer than 7 days but less than 6 months documented by consecutive ECG recordings Failure or intolerance of at least one Class I or III antiarrhythmic drug Age 18 (or older if required by local law) to 80 Left atrial diameter &gt; 5.0 cm (anteroposterior) Prior left atrial ablation or surgical procedure (including left atrial appendage closures) Presence or likely implant of a permanent pacemaker, biventricular pacemaker, loop recorder, or any type of implantable cardiac defibrillator (with or without biventricular pacing function) within 12 months Body mass index (BMI) ≥34 Presence of any pulmonary vein stents Presence of any preexisting pulmonary vein stenosis Preexisting hemidiaphragmatic paralysis Presence of any cardiac valve prosthesis Moderate or severe mitral valve regurgitation or stenosis Any cardiac surgery, myocardial infarction, PCI / PTCA or coronary artery stenting which occurred during the 3 month interval preceding the consent date Unstable angina NYHA Class IV congestive heart failure and/or documented left ventricular ejection fraction (LVEF) less than 45% measure by acceptable cardiac testing (e.g. TTE) Primary pulmonary hypertension Rheumatic heart disease Thrombocytosis, thrombocytopenia Any condition contraindicating chronic anticoagulation Active systemic infection Hypertrophic cardiomyopathy Cryoglobulinemia Uncontrolled hyperthyroidism Any cerebral ischemic event (strokes or TIAs) which occurred during the 6 month interval preceding the consent date Any woman known to be pregnant or breastfeeding, or any woman of child bearing potential who is not on a reliable form of birth regulation method or abstinence Life expectancy less than one year Current or anticipated participation in any other clinical trial of a drug, device or biologic during the duration of the study not preapproved by Medtronic Known allergies or hypersensitivities to adhesives Known drug or alcohol dependency Unwilling or unable to comply fully with study procedures and followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>